Canada markets closed

Hyloris Pharmaceuticals SA (HYL.BR)

Brussels - Brussels Delayed Price. Currency in EUR
Add to watchlist
11.700.00 (0.00%)
At close: 05:37PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
2,814
2,951
3,096
175
91
Cost of Revenue
93
94
107
145
66
Gross Profit
2,721
2,857
2,989
30
25
Operating Expenses
Research Development
14,749
10,151
5,056
3,413
4,577
Selling General and Administrative
5,653
3,517
2,900
2,194
808
Total Operating Expenses
18,810
13,365
13,337
5,586
5,299
Operating Income or Loss
-16,089
-10,508
-10,348
-5,556
-5,274
Interest Expense
393
219
556
992
411
Income Before Tax
-15,762
-10,766
-11,282
-7,145
-5,782
Income Tax Expense
0
4
297
1
-14
Income from Continuing Operations
-15,762
-10,770
-11,579
-7,146
-5,768
Net Income
-15,762
-10,770
-11,579
-7,145
-5,373
Net Income available to common shareholders
-15,762
-10,770
-11,579
-7,145
-5,373
Basic EPS
-0.46
-0.40
-0.45
-0.33
-0.23
Diluted EPS
-0.46
-0.40
-0.45
-0.33
-0.23
Basic Average Shares
-
27,199
25,833
21,819
23,552
Diluted Average Shares
-
27,199
25,833
21,819
23,552